Navigation Links
Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
Date:5/30/2012

SEATTLE, May 30, 2012 /PRNewswire/ -- Aequus BioPharma, Inc. ("Aequus"), a majority owned subsidiary of Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC), announced today that its GlycoPolymer technology proof of concept studies, featuring recent data with their AQB-101 drug candidate, was selected for an oral presentation at the 9th International Symposium for Polymer Therapeutics meeting.  The meeting will be held on May 28-30, 2012, at the Centro de Investigacion Principe Felipe in Valencia, Spain. 

Stewart D. Chipman, Ph.D., the Chief Scientific Officer and President of Aequus, is scheduled to present the data on Wednesday, May 30, 2012, during the "New Technologies and Novel Therapeutic Targets" session that will be held from 8.30 to 13.00 CET.  The presentation is entitled, "AQB-101, A novel glycoprotein with G-CSF activity and a recombinantly ligated amino acid sequence, demonstrates plasma pharmacokinetics comparable to PEG-G-CSF."

Dr. Chipman stated, "The data in this presentation demonstrates thepotential utility of Aequus' proprietary GlycoPolymer technology for extending the plasma half-life of therapeutically useful proteins and peptides that possess limited efficacy due to poor intrinsic pharmacokinetic properties.  Aequus believes that application of its straightforward modular GlycoPolymer technology approach, which utilizes industry standard methods and techniques, to biologically active proteins and peptides will facilitate the development of therapeutic protein-based drugs that require less frequent dosing and offer improved patient convenience." 

"Aequus' presentation will describe how the company has created a novel hG-CSF-based therapeutic protein candidate, AQB-101, by using the GlycoPolymer technology approach.  The AQB-101 glycoprotein possesses a plasma half-life that is comparable to pegylated hG-CSF (Neulasta®), and significantly prolonged compared to hG-CSF (Neupogen&
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... LifeNet Health plans to enlarge its workforce ... more than 160 people. The organization,s growth ... innovative bio-implants, which are being made more widely available ... It also is a reflection of the region,s growing ... and success of LifeNet Health is a great example ...
(Date:5/29/2015)... 2015  Haemonetics Corporation (NYSE: HAE ) announced ... will present at the JMP Securities Life Sciences Conference ... 23 rd , 2015 at 11:30am Eastern time.  ... live via webcast at: http://wsw.com/webcast/jmp27/hae ... is a global healthcare company dedicated to providing innovative ...
(Date:5/29/2015)... , May 29, 2015 Amgen (NASDAQ: ... two pivotal Phase 3, global, randomized, placebo-controlled trials ... treatment of secondary hyperparathyroidism (SHPT) in patients with ... met the primary endpoint, demonstrating that a greater ... achieved a greater than 30 percent reduction in ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7
... Sagent Pharmaceuticals, Inc., a privately held specialty ... Drug Administration had granted tentative approval of adenosine injection, ... 60 mg per 20 mL and 90 mg per ... U.S. innovator market for these adenosine presentations approximated ...
... XIANYANG, China , ... Bulletin Board: BSPM) ("Biostar" or "the Company"),a Xianyang-based ... Aoxing Oleanolic Acid Capsules ("Xin Aoxing"), and a ... was approved by,NASDAQ to list its common stock ...
Cached Medicine Technology:Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations 2Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 2Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 3Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 4
(Date:5/29/2015)... (PRWEB) May 29, 2015 Abington ... be among the first hospitals in the nation ... enhance maternity care practices and work toward achieving ... hospital-based quality-improvement initiative focusing on maternity care practices ... for Disease Control and Prevention, EMPower is aimed ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 The ... greatly in the last decade. New and more efficient methods ... hair available to balding patients. One of the most cutting ... Parsa Mohebi Hair Restoration is the technique of extracting hair ... to scalp transplants are performed to correct male pattern ...
(Date:5/29/2015)... Port Richey, FL (PRWEB) May 29, 2015 ... that nearly one in 10 full-time workers has a substance ... and 2012 from more than 111,500 adults with full-time jobs, ... alcohol disorder in the previous year. (1) The National Council ... employers $81 billion per year, and an estimated 70% of ...
(Date:5/29/2015)... May 29, 2015 Red Hot & ... newest Red Hot & Blue restaurant at 525 New Waverly ... May 7, 2015. “The Red Hot & Blue Restaurant was ... years, but we have moved to a new location in ... the middle of all the activities on the Promenade–with outdoor ...
(Date:5/29/2015)... May 29, 2015 To compile the ... choosing systems that have several awards for clinical and ... what systems stood out to them in terms of ... as well. , The 50 Great Health Systems to ... Health System (Altamonte Springs, Fla.) , Advocate Health Care ...
Breaking Medicine News(10 mins):Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3
... whose parents have high expectations for their ability to ... other children dealing with the condition, according to a ... asthma controller medications appropriately if they have a routine ... how well symptoms can be controlled. , The study, ...
... many calories they are actually consuming, which can hinder ... person would overestimate the amount of exercise they,re doing, ... a study to be presented at The Obesity Society,s ... a Lead Health Services Specialist at Temple,s Center for ...
... Food and Drug,Administration (FDA) reopened discussions on ... dispensing decongestants, antihistamines and cough,suppressants to children, ... the,estimated benefits for children based on using ... in adults., (Photo: http://www.newscom.com/cgi-bin/prnh/20081003/NEF040-a ...
... Discrimination; Recognizes,Importance of Mental Health to Overall ... Mental Health,America today hailed as "a great ... health parity legislation that will broadly outlaw ... and substance-use,conditions in employer-sponsored health plans., ...
... As the population ages, a big,question employers must start asking ... In most cases the answer is no. 95% of ... provide for their families. What,happens when one of the spouses ... drops for the person that is sick but the healthy,employee/spouse ...
... General surgeon salary survey shows 40 percent imagine negative income impact. ... ... Although the economy currently dominates both the news media and the ... for the new president, according to recent survey results. But how ...
Cached Medicine News:Health News:Children's asthma affected by parental expectations 2Health News:Safe New Children's Medicines Launched for Cough, Cold and Flu Season 2Health News:Safe New Children's Medicines Launched for Cough, Cold and Flu Season 3Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2Health News:LocumTenens.com Reaps Mixed Reviews on Universal Healthcare 2Health News:LocumTenens.com Reaps Mixed Reviews on Universal Healthcare 3